U.S. flag

An official website of the United States government

NM_001365088.1(SLC12A6):c.1950dup (p.Leu651fs) AND Agenesis of the corpus callosum with peripheral neuropathy

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 23, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002281814.1

Allele description [Variation Report for NM_001365088.1(SLC12A6):c.1950dup (p.Leu651fs)]

NM_001365088.1(SLC12A6):c.1950dup (p.Leu651fs)

Gene:
SLC12A6:solute carrier family 12 member 6 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
15q14
Genomic location:
Preferred name:
NM_001365088.1(SLC12A6):c.1950dup (p.Leu651fs)
HGVS:
  • NC_000015.10:g.34244071dup
  • NG_007951.1:g.98999dup
  • NM_001042494.2:c.1773dup
  • NM_001042495.2:c.1773dup
  • NM_001042496.2:c.1923dup
  • NM_001042497.2:c.1905dup
  • NM_001365088.1:c.1950dupMANE SELECT
  • NM_005135.2:c.1797dup
  • NM_133647.2:c.1950dup
  • NP_001035959.1:p.Leu592fs
  • NP_001035960.1:p.Leu592fs
  • NP_001035961.1:p.Leu642fs
  • NP_001035962.1:p.Leu636fs
  • NP_001352017.1:p.Leu651fs
  • NP_005126.1:p.Leu600fs
  • NP_598408.1:p.Leu651Serfs
  • NP_598408.1:p.Leu651fs
  • LRG_270t1:c.1797dup
  • LRG_270t2:c.1945dup
  • LRG_270:g.98999dup
  • LRG_270p1:p.Leu600fs
  • LRG_270p2:p.Leu651Serfs
  • NC_000015.9:g.34536266_34536267insA
  • NC_000015.9:g.34536272dup
  • NM_133647.1:c.1945dup
  • NM_133647.1:c.1950dupT
Protein change:
L592fs
Molecular consequence:
  • NM_001042494.2:c.1773dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001042495.2:c.1773dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001042496.2:c.1923dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001042497.2:c.1905dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001365088.1:c.1950dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_005135.2:c.1797dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_133647.2:c.1950dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Agenesis of the corpus callosum with peripheral neuropathy (ACCPN)
Synonyms:
Andermann syndrome; Charlevoix disease; Corpus callosum agenesis neuronopathy; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0000902; MedGen: C0795950; Orphanet: 1496; OMIM: 218000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002572280Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Aug 23, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002572280.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: SLC12A6 c.1950dupT (p.Leu651SerfsX68) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory and also observed in the HGMD database. The variant was absent in 251226 control chromosomes. To our knowledge, no occurrence of c.1950dupT in individuals affected with Andermann Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024